US 7723018
Methods of assaying for cell cycle modulators using components of the ubiquitin ligation cascade
granted A61KA61K31/713A61K38/53
Quick answer
US patent 7723018 (Methods of assaying for cell cycle modulators using components of the ubiquitin ligation cascade) held by Rigel Pharmaceuticals, Inc. expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/713, A61K38/53